This event is co-sponsored by:
LES Houston Chapter presents:
March-In Rights: Can they really do that?
An Expert Panel Discussion
Did you know that the Bayh-Dole Act allows universities and companies to own inventions discovered with federal funding, but in exchange, and under certain circumstances, the government can “march in” to force licensing of the patent rights? Come listen to the experts speak to March-In rights of federally funded inventions. Learn about the circumstances when this could happen as well as the probability of it happening. Hear about the few cases that have been brought where the government was asked to “march in.” While March-In rights loom across industries, certain advocate groups are now proposing creative governmental price control solutions using new interpretations of such rights. Is this misuse or not? Please join us as our panelists address and dissect the various aspects of this law.
CLE: One hour of CLE credit is being applied for.
Light hors d'oeuvres, beer, wine and soft drinks.
Thursday, February 27, 2020
4:30 p.m. - 7:00 p.m.
JLABS @ TMC
2450 Holcombe Blvd. Suite J
Houston, TX 77021
Please enter through ‘Gate 81’ off of Holcombe. Pull a ticket (parking will be validated) and turn right towards the ‘TMC Innovation’ sign. Be sure to bring your ticket to the registration desk.
Through February 21:
Nonprofit educational member:$10.00
After February 21:
AIPLA member: $60.00
Nonprofit educational member:$10.00
Moderator - Jeremy McKown, J.D.
Jeremy is the Vice-President of Law for Janssen Research and Development, LLC., a subsidiary of Johnson & Johnson (J&J), where he leads a multi-disciplinary team in drafting, negotiating and executing contracts to accelerate Janssen’s pharmaceutical pipeline from the lab to patents. Prior to this role, Jeremy managed global teams of attorneys and patent professionals dedicated to identifying, protecting and monetizing the intellectual property of J&J's Pharmaceutical and Consumer businesses. Previous to J&J, he worked as a Senior Counsel – Patents for Schering Plough, and in private practice in Washington, DC. Jeremy has a B.S. in Chemistry from Ithaca College, a M.S. in Chemistry from Bucknell University and a J.D. from Syracuse University College of Law.
Panelist - Ferran Prat, Ph.D., J.D
Ferran is Senior Vice President, Research Administration and Industry Relations for MD Anderson Cancer Center. Previously, he worked at Alere Inc., an international firm dedicated to developing health management services and solutions, including diagnostic tools and tests. At Alere, Ferran led a business turnaround and integrated three businesses in São Paulo and Belo Horizonte, Brazil. He also served as the head of the Oncology and Women’s Health Divisions in San Diego, where he was responsible for all pre-commercialization activities and post-launch product management.
Prior to Alere, Ferran held a number of industry and academic positions, including vice president for licensing at Biosite Inc., management consultant at McKinsey & Co., engineer at Chromogenia-Units and researcher at the University of California – Los Angeles. In these roles, he in-licensed and out-licensed new technologies, led and executed strategic plans, coordinated intellectual property agreements among private and public sector entities, and conducted basic science research that led to multiple peer-reviewed articles. Ferran has a Ph.D. in organic chemistry from the University of California – Los Angeles and a J.D. from the University of San Diego School of Law.
Panelist - Don Ware, J.D.
Don Ware is Co-Chair of the Patent Litigation practice at FoleyHoag, LLC in Boston, MA. Don represents leading biopharma manufacturers, research institutions, and universities in patent and inventorship disputes, technology transfer issues, and intellectual property strategy. He also advises clients on FDA matters, including the FDA's regulatory pathway for approval of biosimilars, and issues arising under the Bayh-Dole Act. He has represented the patent holders in several Bayh-Dole March-In proceedings, including the first such proceeding, In re CellPro, Inc. Don has a J.D. from Harvard Law School and a A.B. from Yale College.
Panelist - George Webb, J.D.
George is the McNair Center scholar for entrepreneurship at Rice University, where he leads the analysis of entrepreneurial ecosystems and identifies opportunities and priorities for collaboration with start-up accelerators, technology incubators, and other segments of the Houston entrepreneurial community. He is also the industry liaison for the Rice University School of Engineering. George came to Rice after many years in private practice as a patent attorney, representing clients ranging from solo inventors to technology companies including Apple, Hewlett-Packard, Xerox, Lenovo, Acer, Amkor and AnologicTech. In that capacity, he was one of a handful of U.S. lawyers selected for the Global Fellows program, an international collaboration of the Federal Circuit Bar Association, and the German Association for the Protection of Intellectual Property. George earned a J.D. from Tulane University Law School and master’s and bachelor’s degrees in electrical engineering from Rice.
The Houston chapter uses online registration for members and non-members and accepts payment by credit card. Members should login to the registration page with their LES online account.
A $5.00 cancellation fee is applied to all refunds. Cancellations are non-refundable after February 21. Substitutions will be accepted. Contact LES at (703) 234-4058 for assistance.
Requests for ADA accommodations and special dietary needs should be submitted to the event contact listed at the top of the page.
By registering for this event, you permit LES and its chapters to use photographs of you with or without your name and for any lawful purpose, including for example such purposes as publicity, illustration, advertising, and web content.
By registering for this event, you permit LES and its chapters to use your email address to communicate with you regarding LES events and their other services. You will have the ability to unsubscribe from these communications going forward.